animals |
9 |
cell differentiation - drug effects |
9 |
induced pluripotent stem cells |
9 |
mice |
9 |
calcium - metabolism |
8 |
cardiac differentiation |
8 |
cardiomyocytes |
8 |
cardiomyopathy |
8 |
cell line |
8 |
cell movement - drug effects |
8 |
embryonic stem cell |
8 |
embryonic stem cells |
8 |
embryonic stem cells - cytology - drug effects - transplantation |
8 |
embryonic stem cells - cytology - metabolism |
8 |
ferric compounds - adverse effects |
8 |
green fluorescent proteins - analysis - biosynthesis |
8 |
hypoxia |
8 |
magnetic resonance imaging - methods |
8 |
myocytes, cardiac - cytology - drug effects |
8 |
nanoparticles - adverse effects |
8 |
staining and labeling - methods |
8 |
superparamagnetic iron oxide |
8 |
anoxia - metabolism |
7 |
antigens, differentiation - biosynthesis |
7 |
antimutagenic agents - pharmacology |
7 |
biology |
7 |
cell differentiation |
7 |
cells, cultured |
7 |
cobalt - pharmacology |
7 |
cytokines - biosynthesis |
7 |
embryonic stem cells - cytology |
7 |
heart - physiology |
7 |
homeostasis - drug effects |
7 |
humans |
7 |
hypoxia inducible factor-1α |
7 |
hypoxia-inducible factor 1, alpha subunit - biosynthesis |
7 |
models, biological |
7 |
myocardium - cytology - metabolism |
7 |
myocardium - metabolism |
7 |
organ specificity - drug effects |
7 |
rna, messenger - metabolism |
7 |
sarcoplasmic reticulum function |
7 |
signal transduction |
7 |
troponin t - biosynthesis |
7 |
up-regulation |
7 |
vascular endothelial growth factor a - metabolism |
7 |
aged |
6 |
apolipoprotein a-i - metabolism |
6 |
calcium handling |
6 |
deferiprone |
6 |
friedreich ataxia |
6 |
friedreich's ataxia |
6 |
homeostasis |
6 |
human induced pluripotent stem cells |
6 |
idebenone |
6 |
induced pluripotent stem cells - cytology |
6 |
myocytes, cardiac - cytology/drug effects - metabolism |
6 |
pluripotent stem cells - cytology |
6 |
atrial fibrillation |
5 |
atrial fibrillation - pathology - therapy |
5 |
autophagy |
5 |
calcium signaling |
5 |
dilated cardiomyopathy |
5 |
electric countershock |
5 |
electrical cardioversion |
5 |
electrical stimulation |
5 |
embryonic stem cells - cytology - drug effects - metabolism |
5 |
embryonic stem cells - drug effects - enzymology - physiology |
5 |
endothelial cells - cytology |
5 |
endothelial progenitor cells |
5 |
genome - genetics |
5 |
glycogen storage disease type iib |
5 |
hematopoietic stem cells - cytology |
5 |
human embryonic stem cells |
5 |
lmna |
5 |
mus |
5 |
myocytes, cardiac - drug effects - enzymology - physiology |
5 |
species index: animalia |
5 |
triiodothyronine - pharmacology |
5 |
x-linked vacuolar cardiomyopathy and myopathy |
5 |
biological evolution |
4 |
cardiotonic agents - pharmacology |
4 |
cardiovascular diseases |
4 |
cell hypoxia |
4 |
chronic periodontitis |
4 |
chronic periodontitis - metabolism - pathology |
4 |
dcm-associated mutations |
4 |
endothelial cells - metabolism - pathology |
4 |
epithelial cells - metabolism - pathology |
4 |
familial dilated cardiomyopathy |
4 |
gene expression - drug effects |
4 |
hypoxia-inducible factor 1-α subunit |
4 |
intracellular signaling peptides and proteins - genetics |
4 |
ipscs-derived cardiomyocyte-based disease model |
4 |
ipscs-derived cerebral cortical neurons |
4 |
lamin a/c |
4 |
lamin a/c cardiomyopathy |
4 |
lamp2 deficiency |
4 |
lysosomal membrane permeabilization |
4 |
mitogen-activated protein kinase 1 - metabolism |
4 |
mitogen-activated protein kinase 3 - metabolism |
4 |
myocytes, cardiac - cytology - drug effects - metabolism |
4 |
neuropeptides - genetics |
4 |
nonsense mutation |
4 |
ouabain |
4 |
ouabain - pharmacology |
4 |
oxidative stress-induced apoptosis |
4 |
patient-specific-induced pluripotent stem cells |
4 |
ptc124 |
4 |
receptors, g-protein-coupled - genetics |
4 |
receptors, gastrointestinal hormone - genetics |
4 |
regenerative medicine |
4 |
stem cell model |
4 |
transgenic mice model |
4 |
translational read through |
4 |
tumor necrosis factor-alpha |
4 |
vascular endothelial growth factor a |
4 |
aneuploidy |
3 |
cardiovascular disease |
3 |
carotid body |
3 |
caveolin-1 |
3 |
chromosome disorders - genetics - metabolism - physiopathology |
3 |
gene expression |
3 |
gene transfer techniques |
3 |
hypertrophic cardiomyopathy |
3 |
induced pluripotent stem cell |
3 |
induced pluripotent stem cells - cytology - metabolism |
3 |
intermittent hypoxia |
3 |
intrinsic cardiac abnormality |
3 |
kidney tubules - cytology |
3 |
mecp2 mutation |
3 |
neuroblastoma cells |
3 |
nitric oxide |
3 |
nitric oxide synthases |
3 |
oxidative stress |
3 |
proinflammatory cytokines |
3 |
rett syndrome |
3 |
sleep apnea |
3 |
urine - cytology |
3 |
wnt/β-catenin signaling pathway |
3 |
alzheimer's disease |
2 |
amyloid beta-peptides - metabolism |
2 |
anoxia - drug therapy - metabolism - pathology |
2 |
aspartic acid endopeptidases |
2 |
atherosclerosis |
2 |
beta-site app cleavage enzyme |
2 |
cardioprotection |
2 |
cholesterol |
2 |
chronic intermittent hypoxia |
2 |
congestive cardiomyopathy |
2 |
disease model |
2 |
disease modelling |
2 |
drug screening |
2 |
glycoproteins. |
2 |
high-density lipoproteins |
2 |
hippocampus - drug effects - metabolism - pathology |
2 |
intracellular calcium |
2 |
melatonin |
2 |
melatonin - pharmacology - therapeutic use |
2 |
patient-specific induced pluripotent stem cells |
2 |
protein-protein interactions. |
2 |
x-linked cardiomyopathy |
2 |
β-amyloid |
2 |
β-amyloid precursor protein |
2 |